-
EP1216047
European procedure
Extract from the Register of European Patents
EP About this file: EP1216047
| EP1216047 - COMBINATION OF LOTEPREDNOL AND BETA2-ADRENOCEPTOR AGONISTS AND ITS USE BY INHALATION FOR THE TREATMENT OF BRONCHIAL ASTHMA [Right-click to bookmark this link] | |||
| Former [2002/26] | NOVEL COMBINATION OF LOTEPREDNOL AND BETA2-ADRENOCEPTOR AGONISTS | ||
| [2005/14] | Status | No opposition filed within time limit Status updated on 18.08.2006 Database last updated on 09.05.2025 | Most recent event Tooltip | 18.08.2006 | No opposition filed within time limit | published on 20.09.2006 [2006/38] | Applicant(s) | For all designated states VIATRIS GmbH & Co. KG Benzstrasse 1 61352 Bad Homburg / DE | [2005/18] |
| Former [2002/26] | For all designated states VIATRIS GmbH & Co. KG Weismüllerstrasse 45 60314 Frankfurt am Main / DE | Inventor(s) | 01 /
SZELENYI, Istvan Händelstrasse 32 90571 Schwaig / DE | 02 /
POPPE, Hildegard Kieler Strasse 6 01109 Dresden / DE | 03 /
HEER, Sabine Lindenauer Strasse 13 01445 Radebeul / DE | 04 /
ENGEL, Jürgen Erlenweg 3 63755 Alzenau / DE | [2002/26] | Representative(s) | (deleted) | [2003/51] |
| Former [2002/26] | Wibbelmann, Jobst, Dr., Dipl.-Chem., et al Wuesthoff & Wuesthoff, Patent- und Rechtsanwälte, Schweigerstrasse 2 81541 München / DE | Application number, filing date | 00969304.5 | 26.09.2000 | [2002/26] | WO2000EP09392 | Priority number, date | DE1999147235 | 30.09.1999 Original published format: DE 19947235 | [2002/26] | Filing language | DE | Procedural language | DE | Publication | Type: | A2 Application without search report | No.: | WO0122956 | Date: | 05.04.2001 | Language: | DE | [2001/14] | Type: | A2 Application without search report | No.: | EP1216047 | Date: | 26.06.2002 | Language: | DE | The application published by WIPO in one of the EPO official languages on 05.04.2001 takes the place of the publication of the European patent application. | [2002/26] | Type: | B1 Patent specification | No.: | EP1216047 | Date: | 12.10.2005 | Language: | DE | [2005/41] | Search report(s) | International search report - published on: | EP | 11.10.2001 | Classification | IPC: | A61K31/57, A61K31/165, A61K31/56, A61P11/00, A61P11/06, A61K31/167, A61K9/12, A61K31/522, A61K31/135 | [2005/14] | CPC: |
A61K9/0075 (EP,US);
A61K31/167 (EP,US);
A61K31/56 (EP,US);
A61K45/06 (EP,US);
A61P11/00 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P25/02 (EP);
A61P27/14 (EP);
A61P37/08 (EP)
(-)
| C-Set: |
A61K31/167, A61K2300/00 (EP,US);
A61K31/56, A61K2300/00 (US,EP) |
| Former IPC [2002/26] | A61K31/57, A61K31/165, A61K31/56, A61P11/00 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/26] | Title | German: | KOMBINATION VON LOTEPREDNOL UND BETA2-ADRENOZEPTOR-AGONISTEN UND IHRE VERWENDUNG DURCH INHALATION ZUR BEHANDLUNG VON ASTHMA BRONCHIALE | [2005/14] | English: | COMBINATION OF LOTEPREDNOL AND BETA2-ADRENOCEPTOR AGONISTS AND ITS USE BY INHALATION FOR THE TREATMENT OF BRONCHIAL ASTHMA | [2005/14] | French: | ASSOCIATION DE LOTEPREDNOL ET D'AGONISTES DE L'ADRENOCEPTEUR BETA2 ET SON UTILISATION PAR INHALATION POUR LE TRAITEMENT DE L'ASTHME BRONCHIQUE | [2005/14] |
| Former [2002/26] | NEUE KOMBINATION VON LOTEPREDNOL UND BETA2-ADRENOZEPTOR-AGONISTEN | ||
| Former [2002/26] | NOVEL COMBINATION OF LOTEPREDNOL AND BETA2-ADRENOCEPTOR AGONISTS | ||
| Former [2002/26] | NOUVELLE ASSOCIATION DE LOTEPREDNOL ET D'AGONISTES DE L'ADRENOCEPTEUR BETA2 | Entry into regional phase | 28.02.2002 | National basic fee paid | 28.02.2002 | Designation fee(s) paid | 28.02.2002 | Examination fee paid | Examination procedure | 21.02.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 28.02.2002 | Examination requested [2002/26] | 15.07.2003 | Despatch of a communication from the examining division (Time limit: M06) | 08.01.2004 | Reply to a communication from the examining division | 23.09.2004 | Despatch of a communication from the examining division (Time limit: M04) | 28.10.2004 | Reply to a communication from the examining division | 02.03.2005 | Communication of intention to grant the patent | 27.05.2005 | Fee for grant paid | 27.05.2005 | Fee for publishing/printing paid | Opposition(s) | 13.07.2006 | No opposition filed within time limit [2006/38] | Fees paid | Renewal fee | 23.09.2002 | Renewal fee patent year 03 | 18.09.2003 | Renewal fee patent year 04 | 28.09.2004 | Renewal fee patent year 05 | 30.09.2005 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US5830490 (WEINSTEIN ROBERT E [US], et al) [X] 1 * claims 1,3 *; | [PX]WO0028979 (SKYEPHARMA AG [CH], et al) [PX] 1-6 * claims 1,7,8,14,15 ** page 13, line 25 - page 14, line 20 *; | [X] - L.BJERMER, L.LARSSON, "Long-acting beta-2-agonists: how are they used in an optimal way?", RESPIRATORY MEDICINE, (1997), vol. 91, no. 10, pages 587 - 591, XP000992766 [X] 1,4 * page 587 * * page 588 * * page 590, column 1 * DOI: http://dx.doi.org/10.1016/S0954-6111(97)90004-4 | [X] - T. VAN DER MOLEN E.A., "Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids", THORAX, (1997), vol. 52, no. 6, pages 535 - 539, XP000992767 [X] 1,4 * page 535 * * page 537 * * page 538, column 2 * * page 539, column 1 * |